aditi3019

1
Global Biosimilars Market 2020-2023
Industry Survey, Growth, Competitive
Landscapeand Forecasts to 2023
2
Global Biosimilars Market 2020-2023
Global Biosimilars Market Overview
The global biosimilars market is rising with a
swift phase mainly owing to enhanced
productivity and clinical trial activities for
biosimilars and increasing demand for the cheap
medical products. There are many recently
development due to the expiry of patient of
original drugs. In 2015, The U.S. Food and Drug
Administration approved Erelzi, (etanercept-szzs)
for multiple inflammatory diseases. Erelzi is a
biosimilar to Enbrel (etanercept), which was
originally licensed in 1998 and in 2016, FDA
approved Amjevita (adalimumab-atto) as a
biosimilar to Humira (adalimumab) for multiple
inflammatory diseases. Companies are continuously
invent new products to capture the market
globally. Thus major players invest more in
research and development activity, in order to
lead the global market. In this regards, Pfizer
Inc., in 2016 announced that it has acquired
Bamboo Therapeutics, Inc., in order to lead the
market. This acquisition combines the technology
and research development and enhance
potentially life-changing therapies. PF-05280014,
PF-05280586 and PF-06410293 are under biosimilars
clinical trials. It is third largest contributor
for biosimilars market. Also In 2016, Teva and
Celltrion announce exclusive biosimilar
commercial partnership. Teva Pharmaceutical share
around 20 of total global biosimilars market.
3
Global Biosimilars Market 2020-2023
Global Biosimilars Market Regional Analysis
Europe has dominating market for the biosimilars
market owing to presence of huge patient
population and also major player of Germany,
France who have more focused in exporting the
drugs to developing region of Asia
Pacific. Recently in 2017, The U.S. Food and Drug
Administration approved first biosimilar for the
treatment of cancer, Mvasi (bevacizumab-awwb) as
a biosimilar to Avastin (bevacizumab) for the
treatment of multiple types of cancer. The
Americas has second leading market for
biosimilars players, owing to present of huge
population affected with disease. According to
Centers for Disease Control and Prevention (CDC),
in 2014, seven of the top ten causes of death
were chronic diseases that are heart disease and
cancer. Asia Pacific and the Middle East and
Africa region are considering the huge market.
Whereas country like India and china of Asia
Pacific region are considering fastest growing
region due to presence of huge population
effected with chronic disease, additionally they
are open to adopt drugs at lower
cost. Browse Complete Report with TOC _at_  https//w
ww.marketresearchfuture.com/reports/biosimilars-ma
rket-1329
4
Global Biosimilars Market 2020-2023
Global Biosimilars Market Key Players

• Pfizer Inc. (U.S.)
• Teva Pharmaceuticals Industries Ltd. (Israel)
• Sandoz International GmbH (Germany)
• Celltrion, Inc. (South Korea)
• Astra Zeneca (UK)
• Amgen Inc. (U.S.)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Biocon Ltd. (India)
• Dr. Reddys Laboratories Ltd. (India)
• Avail Free Sample _at_ https//www.marketresearchfutu
  re.com/sample_request/1329

5
ABOUT US
MARKET RESEARCH FUTURE At Market Research Future
(MRFR), we enable our customers to unravel the
complexity of various industries through our
Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports
(3R), Continuous-Feed Research (CFR), and Market
Research Consulting Services. MRFR team have
supreme objective to provide the optimum quality
market research and intelligence services to our
clients. Our market research studies by products,
services, technologies, applications, end users,
and market players for global, regional, and
country level market segments, enable our clients
to see more, know more, and do more, which help
to answer all their most important questions. In
order to stay updated with technology and work
process of the industry, MRFR often plans
conducts meet with the industry experts and
industrial visits for its research analyst
members. For more information kindly visit
www.marketresearchfuture.com or contact us at
info_at_marketresearchfuture.com Copyright 2018
Market Research Future All Rights Reserved. This
document contains highly confidential information
and is the sole property of Market Research
Future. No part of it may be circulated, copied,
quoted, or otherwise reproduced without the
written approval of Market Research Future.
6
(No Transcript)